Press Releases

Press Releases

Mar 31, 2020
BOSTON and LONDON , March 31, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics  (Nasdaq: ORTX), a global leader in gene therapy, today provided an update on its business and operations, outlining how the COVID-19 pandemic has and may continue to impact the company’s development programs and timelines,
The site uses cookies to provide you with a more responsive and personalized service. By using this site, you agree to our use of cookies as set out in our cookie notice.

Please read our privacy notice and cookie notice for more information on the cookies we use and how to delete or block the use of cookies.